Ruf C - Search Results

1

Therapy of clinical stage IIA and IIB seminoma: a systematic review.

Heinzelbecker J, Schmidt S, Lackner J, Busch J, Bokemeyer C, Classen J, Dieing A, Hakenberg O, Krege S, Papachristofilou A, Pfister D, Ruf C, Schmelz H, Schmidberger H, Souchon R, Winter C, Zengerling F, Kliesch S, Albers P, Oing C. Heinzelbecker J, et al. Among authors: ruf c. World J Urol. 2022 Dec;40(12):2829-2841. doi: 10.1007/s00345-021-03873-5. Epub 2021 Nov 15. World J Urol. 2022. PMID: 34779882 Free PMC article.

2

[Value of targeted treatment for testicular cancer: from molecular approaches to clinical possibilities].

Martinschek A, Ruf CG, Sparwasser C, Schmelz HU. Martinschek A, et al. Among authors: ruf cg. Urologe A. 2008 Oct;47(10):1328-33. doi: 10.1007/s00120-008-1750-1. Urologe A. 2008. PMID: 18587552 Review. German.

3

Testis cancer cells have a genetic determination for a high sensitivity to apoptosis inducing stimuli.

Schmelz HU, Port M, Stockinger M, Ruf C, Martinscheck A, Sparwasser C, Weidner W, Abend M. Schmelz HU, et al. Among authors: ruf c. Urol Oncol. 2010 Jan-Feb;28(1):49-58. doi: 10.1016/j.urolonc.2008.11.003. Epub 2009 Jan 22. Urol Oncol. 2010. PMID: 19162512

4

A gene signature of primary tumor identifies metastasized seminoma.

Port M, Wang Y, Schmelz HU, Pottek T, Meineke V, Ruf C, Abend M. Port M, et al. Among authors: ruf c. Urol Oncol. 2011 Nov-Dec;29(6):764-73. doi: 10.1016/j.urolonc.2009.08.008. Epub 2009 Nov 27. Urol Oncol. 2011. PMID: 19945308

5

Predicting metastasized seminoma using gene expression.

Ruf CG, Linbecker M, Port M, Riecke A, Schmelz HU, Wagner W, Meineke V, Abend M. Ruf CG, et al. BJU Int. 2012 Jul;110(2 Pt 2):E14-20. doi: 10.1111/j.1464-410X.2011.10778.x. Epub 2012 Jan 13. BJU Int. 2012. PMID: 22243760

6

The search for biomarkers of metastatic seminoma.

Ruf CG, Khalili-Harbi N, Sachs S, Isbarn H, Wagner W, Matthies C, Meineke V, Fisch M, Chun FK, Abend M. Ruf CG, et al. J Urol. 2013 Sep;190(3):1046-51. doi: 10.1016/j.juro.2013.04.022. Epub 2013 Apr 10. J Urol. 2013. PMID: 23583226

7

Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.

Dieckmann KP, Radtke A, Spiekermann M, Balks T, Matthies C, Becker P, Ruf C, Oing C, Oechsle K, Bokemeyer C, Hammel J, Melchior S, Wosniok W, Belge G. Dieckmann KP, et al. Among authors: ruf c. Eur Urol. 2017 Feb;71(2):213-220. doi: 10.1016/j.eururo.2016.07.029. Epub 2016 Aug 2. Eur Urol. 2017. PMID: 27495845 Free article.

8

Corrigendum re: "Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours" [Eur Urol 2017;71:213-20].

Dieckmann KP, Radtke A, Spiekermann M, Balks T, Matthies C, Becker P, Ruf C, Oing C, Oechsle K, Bokemeyer C, Hammel J, Melchior S, Wosniok W, Belge G. Dieckmann KP, et al. Among authors: ruf c. Eur Urol. 2017 May;71(5):e161. doi: 10.1016/j.eururo.2017.01.041. Epub 2017 Feb 13. Eur Urol. 2017. PMID: 28209431 No abstract available.

9

Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance-A systematic review.

Zengerling F, Kunath F, Jensen K, Ruf C, Schmidt S, Spek A. Zengerling F, et al. Among authors: ruf c. Urol Oncol. 2018 Oct;36(10):448-458. doi: 10.1016/j.urolonc.2017.06.047. Epub 2017 Jul 13. Urol Oncol. 2018. PMID: 28712790

10

Thromboprophylaxis and the route of administration of chemotherapy in testicular cancer patients in German-speaking countries.

Nestler T, Huber J, Laury AM, Isbarn H, Heidenreich A, Schmelz HU, Ruf CG. Nestler T, et al. World J Urol. 2018 Jun;36(6):913-920. doi: 10.1007/s00345-018-2222-x. Epub 2018 Feb 7. World J Urol. 2018. PMID: 29417289

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page